This reliance on AR signaling makes androgen depravation therapy (ADT) an effective way to limit prostate cancer tumor growth; initially tumors respond well to anti-androgen therapy, dramatically shrinking in size and patients see a reduction in cancer symptoms. Here, AR is linked to neoplasm.